Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Graft Enhancement, Immunologic MeSH Descriptor Data 2026


MeSH Heading
Graft Enhancement, Immunologic
Tree Number(s)
E02.095.465.425.450.440
E05.478.610.500
Unique ID
D006082
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D006082
Scope Note
The induction of prolonged survival and growth of allografts of either tumors or normal tissues which would ordinarily be rejected. It may be induced passively by introducing graft-specific antibodies from previously immunized donors, which bind to the graft's surface antigens, masking them from recognition by T-cells; or actively by prior immunization of the recipient with graft antigens which evoke specific antibodies and form antigen-antibody complexes which bind to the antigen receptor sites of the T-cells and block their cytotoxic activity.
Entry Version
GRAFT ENHANCEMENT IMMUNOL
Entry Term(s)
Enhancement, Immunologic Graft
Graft Enhancement
Graft Enhancement, Immunological
Immunologic Enhancement of Grafts
Immunologic Graft Enhancement
Previous Indexing
Graft Survival (1977-1979)
Transplantation, Homologous (1966-1979)
Transplantation Immunology (1966-1979)
Public MeSH Note
80
History Note
80
Date Introduced
1980/01/01
Last Updated
2009/07/06
Graft Enhancement, Immunologic Preferred
Graft Enhancement Broader
page delivered in 0.162s